Factors affecting continuation rates of opicapone: A retrospective study at a single center in Japan.

Ongentys (opicapone) - Ono Pharma, Neurocrine, BIAL

http://www.ncbi.nlm.nih.gov/pubmed/40168701

Akira Yokote; Hidetoshi Kamimura; Kentaro Ogata; Takayasu Mishima; Yasuhiko Baba; Yuki Yasutaka

Apr 1, 2025